Nonopioid analgesic pipeline: Pharmacology, safety, tolerability, and potential advantages over established agents

Ropper, 2009, Pain Attal, 1999, Mechanisms of pain in peripheral neuropathy, Acta Neurol Scand Suppl, 173, 12, 10.1111/j.1600-0404.1999.tb07386.x Fauci, 2008, Pain: Pathophysiology and management Morgan, 2006, Pain management Kroenke, 2009, Pharmacotherapy of chronic pain: A synthesis of recommendations from systematic reviews, Gen Hosp Psychiatry, 31, 206, 10.1016/j.genhosppsych.2008.12.006 Sternbach, 1986, Survey of pain in the United States: The Nuprin pain, Clin J Pain, 2, 49, 10.1097/00002508-198602010-00008 Stewart, 2003, Lost productive time and cost due to common pain conditions in the US workforce, J Am Med Assoc, 290, 2443, 10.1001/jama.290.18.2443 Tremon-Lukats, 2000, Anticonvulsants for neuropathic pain syndromes: Mechanisms of action and place in therapy, Drugs, 60, 1029, 10.2165/00003495-200060050-00005 Hyllested, 2002, Comparative effect of paracetamol, NSAIDs, or their combination in post operative pain management: A qualitative review, Br J Anaesth, 88, 199, 10.1093/bja/88.2.199 Shaojun, 2008, Clinical use and pharmacologic properties of selective COX-2 inhibitor, Eur J Clin Pharmacol, 64, 233, 10.1007/s00228-007-0400-7 Pincus, 2004, Patient preference for placebo, acetaminophen (paracetamol) or celecoxib efficacy studies (PACES): Two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis, Ann Rheum Dis, 63, 931, 10.1136/ard.2003.020313 Katzung, 2009 Campbell, 1966, Clinical trial of carbamazepine (Tegretol) in trigeminal neuralgia, J Neurosurg Neurol Psychiatry, 29, 265, 10.1136/jnnp.29.3.265 Killian, 1968, Carbamazepine in the treatment of neuralgia, Arch Neurol, 19, 129, 10.1001/archneur.1968.00480020015001 Rull, 1969, Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine: Double-blind crossover study, Diabetologia, 5, 215, 10.1007/BF01212087 Nicol, 1969, A four year double blind randomized study of Tegretol in facial pain, Headache, 9, 54, 10.1111/j.1526-4610.1969.hed0901054.x McKellar, 2009, Celecoxib in arthritis: Relative risk management profile and implications for patients, Ther Clin Risk Manag, 5, 889, 10.2147/TCRM.S3131 Wiffen, 2005, Gabapentin for acute and chronic pain, Cochrane Database Syst Rev, 3 Backonja, 1998, Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial, J Am Med Assoc, 280, 1831, 10.1001/jama.280.21.1831 Rowbotham, 1998, Gabapentin for the treatment of post-herpetic neuralgia: A randomized controlled trial, J Am Med Assoc, 280, 1837, 10.1001/jama.280.21.1837 Detrembleur, 2005, Celecoxib improves the efficiency of the locomotor mechanism in patients with knee osteoarthritis, Osteoarthritis Cartilage, 13, 206, 10.1016/j.joca.2004.11.002 Stern, 2008 Bradley, 2004 Max, 1992, Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy, N Engl J Med, 326, 1250, 10.1056/NEJM199205073261904 Pfizer: Lyrica (pregabalin) capsules prescribing information. New York, June 2007 Dworkin, 2003, Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial, Neurology, 60, 1274, 10.1212/01.WNL.0000055433.55136.55 Sabatowski, 2004, Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: Results of a randomised, placebo-controlled clinical trial, Pain, 109, 26, 10.1016/j.pain.2004.01.001 Crofford, 2008, Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): A 6-month, double-blind, placebo-controlled trial with pregabalin, Pain, 136, 419, 10.1016/j.pain.2008.02.027 Lyseng-Williamson, 2008, Pregabalin: A review of its use in fibromyalgia, Drugs, 68, 2205, 10.2165/00003495-200868150-00009 2007, Pregabalin (Lyrica) for fibromyalgia, Med Lett Drugs Ther, 49, 77 Arnold, 2008, A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia, J Pain, 9, 792, 10.1016/j.jpain.2008.03.013 Wymer, 2009, Efficacy and safety of lacosamide in diabetic neuropathic pain: An 18-week double-blind placebo-controlled trial of fixed-dose regimens, Clin J Pain, 25, 376, 10.1097/AJP.0b013e318196d2b6 Wallace MS, Kudrow DB, McElveen WA, et al: Durect pharma: Clinical trial results: A randomized, double-blind, placebo-controlled, trial of three-day bupivicaine patch (Eladur) in patients with post herpetic neuralgia. Chong, 2009, Clinical aspects and management of fibromyalgia syndrome, Ann Academy Med Singapore, 38, 967 Chong, 2009, Clinical aspects and management of fibromyalgia syndrome, Ann Academy Med Singapore, 38, 967 Perucca, 2002, Marketed new antiepileptic drugs: Are they better than old-generation agents?, Ther Drug Monit, 24, 74, 10.1097/00007691-200202000-00013 Ben-Menachem, 2007, Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures, Epilepsia, 48, 1308, 10.1111/j.1528-1167.2007.01188.x Wallace, et al: Clinical Trial results: A randomized, double-blind, placebo-controlled, trial of a three day bupivicaine patch (Eladur) in patients with post-herpetic neuralgia. American Pain Society, 27th Annual Meeting, 2008 Available at: http://www.durect.com/wt/durect/page_name/bupivacaine Available at: http://www.anesiva.com/wt/page/adlea 2009 Clauw, 2008, Milnacipran for the treatment of fibromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial, Clin Ther, 30, 1988, 10.1016/j.clinthera.2008.11.009 Carville, 2008, EULAR evidence-based recommendations for the management of fibromyalgia syndrome, Ann Rheum Dis, 67, 536, 10.1136/ard.2007.071522 Mease, 2009, The efficacy and safety of milnacipran for treatment of fibromyalgia, J Rheumatol, 36, 398, 10.3899/jrheum.080734